Healthy Skepticism Library item: 683

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Evans RG.
Manufacturing consensus, marketing truth: guidelines for economic evaluation.
Ann Intern Med 1995 Jul 1; 123:(1):59-60

Abstract:

Drug companies have become interested in pharmacoeconomics because purchasing decisions about drugs are shifting and therefore they have to shift “communications” strategy, changing its style and content to address the new audience. The primary focus of the Leonard Davis Institute Task Force is with lack of appropriate independence for researchers. But who is going to enforce the new guidelines and how. Marketers fact powerful incentives to push to or beyond the limits of any constraints. Most of the Task Force recommendations essentially say that those who undertake economic analyses should do good and refrain from evil. The Task Force was supported only by a coalition of pharmaceutical companies; presumably the sponsors anticipate that pharmacoeconomic evaluations will eventually promote sales.

Keywords:
*editorial United States pharmacoeconomic analysis conflict of interest drug company sponsored research

Notes:

Comment in:
Ann Intern Med. 1996 Mar 1;124(5):535-6.
Ann Intern Med. 1996 Mar 1;124(5):536.

Comment on:
Ann Intern Med. 1995 Jul 1;123(1):61-70.